Epidemiology study in postmenopausal women with estrogen receptor positive breast cancer
Study identifier:NIS-ORS-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An epidemiological, non-interventional study to evaluate patient compliance in postmenopausal women with estrogen receptor positive breast cancer
Medical condition
Hormon receptor positive breast cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
90
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2011
Primary Completion Date: 01 Nov 2012
Study Completion Date: 01 Nov 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jul 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Women with estrogen receptor positive breast cancer already receiving treatment with an aromatase inhibitor (AI) will be enrolled in the study | - |
Contacts
Contact Backup
AstraZeneca Representative Office for Serbia and Montenegro
Investigators
Principal Investigator
Dr Jasna Pesic
M.D.spec of oncology, Institute for oncology Vojvodina, Sremska Kamenica
